AstraZeneca

AstraZeneca

AstraZeneca’s numbers are good but trouble in China could drag it down | Nils Pratley

In the world of two weeks ago, AstraZeneca’s share price probably would have enjoyed a strong day on the release of Tuesday’s third-quarter numbers. The profit figure beat forecasts...

No posts to display

Editor Picks

Must Read

Hot Topics